RASGRF1 Fusions Activate Oncogenic RAS Signaling and Confer Sensitivity to MEK Inhibition. Hunihan L, Zhao D, Lazowski H, Li M, et al. Clin Cancer Res 2022;28:3091-3103.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hunihan L, Zhao D, Lazowski H, Li M, et al. RASGRF1 Fusions Activate Oncogenic RAS Signaling and Confer Sensitivity to MEK Inhibition. Clin Cancer Res 2022;28:3091-3103.
PMID: 35247929